PHARMAFIN
0808.755.910 · rovalta.com · 23/09/2026
PHARMAFIN
Company — Normal situation.
Overview
What does PHARMAFIN do?
PHARMAFIN is a company registered in Belgium.
Trend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Gross margin | 511,3 k € | +254% | 144,6 k € | +13.4% | 127,5 k € | +110% | 60,7 k € | -6.3% | 64,7 k € | -13.7% | 75 k € | +32.9% | 56,4 k € | -23.7% | 73,9 k € | -0.1% | 73,9 k € | +27.5% | 58 k € | +14.3% | 50,7 k € | +5.7% | 48 k € | -43.9% | 85,5 k € |
| EBITDA | 510,6 k € | +257% | 143,1 k € | +12.7% | 127 k € | +111% | 60,1 k € | -5.7% | 63,7 k € | -13.7% | 73,8 k € | +33.4% | 55,4 k € | -23.8% | 72,6 k € | -0.4% | 72,9 k € | +28.3% | 56,9 k € | +14.4% | 49,7 k € | +8.7% | 45,7 k € | -46.0% | 84,6 k € |
| Operating result | 510,4 k € | +257% | 142,9 k € | +12.7% | 126,7 k € | +112% | 59,8 k € | -3.5% | 62 k € | -14.0% | 72,1 k € | +34.4% | 53,7 k € | -24.4% | 71 k € | -0.4% | 71,3 k € | +25.3% | 56,9 k € | +14.4% | 49,7 k € | +8.7% | 45,7 k € | -45.4% | 83,7 k € |
| Net result | 431,1 k € | +336% | 98,9 k € | +10.5% | 89,5 k € | +119% | 40,9 k € | +17.6% | 34,7 k € | +27.9% | 27,2 k € | +63.3% | 16,6 k € | -59.5% | 41,1 k € | +0.2% | 41 k € | +23.3% | 33,3 k € | +50.6% | 22,1 k € | +11.1% | 19,9 k € | -56.1% | 45,3 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | 899,3 k € | +78.8% | 503 k € | +16.6% | 431,2 k € | -0.0% | 431,4 k € | +48.0% | 291,5 k € | +13.5% | 256,8 k € | +11.8% | 229,6 k € | +7.8% | 212,9 k € | +23.9% | 171,8 k € | +24.5% | 138 k € | +31.8% | 104,7 k € | +26.8% | 82,6 k € | +26.5% | 65,3 k € |
| Total assets | 1,2 M € | +77.4% | 651,4 k € | +23.2% | 528,7 k € | +2.5% | 515,6 k € | +6.4% | 484,7 k € | +1.6% | 476,9 k € | -1.7% | 485,2 k € | -3.8% | 504,2 k € | +2.1% | 493,8 k € | +14.2% | 432,2 k € | -0.1% | 432,6 k € | -9.0% | 475,6 k € | -2.0% | 485,1 k € |
| Cash | 1,1 M € | +604% | 155,3 k € | +200% | 51,7 k € | +34.7% | 38,4 k € | +214% | 12,2 k € | +92.2% | 6,4 k € | +192% | 2,2 k € | -87.2% | 17 k € | +372% | 3,6 k € | -77.1% | 15,8 k € | +33.7% | 11,8 k € | -73.9% | 45,2 k € | -42.9% | 79,2 k € |
| Debts | 256,1 k € | +72.6% | 148,4 k € | +52.2% | 97,5 k € | +18.7% | 82,1 k € | -56.4% | 188,4 k € | -12.4% | 215 k € | -15.2% | 253,4 k € | -11.9% | 287,8 k € | -10.6% | 321,9 k € | +9.4% | 294,2 k € | -10.3% | 327,9 k € | -16.3% | 391,6 k € | -6.4% | 418,3 k € |
Board of directors
Seen on filing of 30/09/2024 · 2 active · 5 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 |
| Closing of the financial year | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/12/2024 | 16/04/2024 | 28/03/2023 | 26/04/2022 | 27/04/2021 | 30/04/2020 |
| General meeting | 09/12/2024 | 15/03/2024 | 17/03/2023 | 30/03/2022 | 31/03/2021 | 31/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
15 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2024 | 09/12/2024 | 23/12/2024 | Dutch | |
| Micro model | 30/09/2023 | 15/03/2024 | 16/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 17/03/2023 | 28/03/2023 | Dutch | |
| Abridged model | 30/09/2021 | 30/03/2022 | 26/04/2022 | Dutch | |
| Abridged model | 30/09/2020 | 31/03/2021 | 27/04/2021 | Dutch | |
| Abridged model | 30/09/2019 | 31/03/2020 | 30/04/2020 | Dutch | |
| Abridged model | 30/09/2018 | 31/03/2019 | 12/04/2019 | Dutch | |
| Abridged model | 30/09/2017 | 30/03/2018 | 25/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 17/03/2017 | 31/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 18/03/2016 | 22/03/2016 | Dutch | |
| Abridged model | 30/09/2014 | 20/03/2015 | 15/04/2015 | Dutch | |
| Abridged model | 30/09/2013 | 21/03/2014 | 10/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 30/03/2013 | 30/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 29/03/2012 | 26/04/2012 | Dutch | |
| Abridged model | 30/09/2010 | 30/03/2011 | 29/04/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/09/2024 · 2 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024431,1 k €↑
- 2023Annual accounts 202398,9 k €↑
- 2022Annual accounts 202289,5 k €↑
- 2021Annual accounts 202140,9 k €↑
- 2018Annual accounts 201834,7 k €↑
- 2017Annual accounts 201727,2 k €↑
- 2016Annual accounts 201616,6 k €↓
- 2015Annual accounts 201541,1 k €↑
- 2014Annual accounts 201441 k €↑
- 2013Annual accounts 201333,3 k €↑
- 2012Annual accounts 201222,1 k €↑
- 2011Annual accounts 201119,9 k €↓
- 2010Annual accounts 201045,3 k €